-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
-
Summary
-
bioAffinity Technologies, Inc. quarterly and annual Amortization of Intangible Assets in USD history and change rate from 30 Sep 2022 to 30 Sep 2025.
- bioAffinity Technologies, Inc. Amortization of Intangible Assets for the quarter ending 30 Sep 2025 was $14,583, unchanged year-over-year.
- bioAffinity Technologies, Inc. Amortization of Intangible Assets for the twelve months ending 30 Sep 2025 was $58,333, a 0% decline year-over-year.
- bioAffinity Technologies, Inc. annual Amortization of Intangible Assets for 2024 was $58,333, a 253% increase from 2023.
- bioAffinity Technologies, Inc. annual Amortization of Intangible Assets for 2023 was $16,528.